SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-23-001198
Filing Date
2023-08-01
Accepted
2023-08-01 06:30:32
Documents
14
Period of Report
2023-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 IDEXX LABORATORIES, INC. 8-K a53494439.htm   iXBRL 8-K 32378
2 EXHIBIT 99.1 a53494439ex99_1.htm EX-99.1 876663
6 idexxlogo.jpg GRAPHIC 3406
  Complete submission text file 0001157523-23-001198.txt   1099879

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA idxx-20230801.xsd EX-101.SCH 3856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE idxx-20230801_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idxx-20230801_pre.xml EX-101.PRE 16038
8 EXTRACTED XBRL INSTANCE DOCUMENT a53494439_htm.xml XML 4063
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

IRS No.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 231129538
SIC: 2835 In Vitro & In Vivo Diagnostic Substances